Is magnetic resonance imaging useful in early evaluation of women on neoadjuvant chemotherapy for locally advanced cervical cancer?

European Journal of Gynaecological Oncology

Volumn 33, Issue 1, 2012, Pages 31-36

  Sala, P ^a   Marchiole P ^b   Cittadini, G ^c   Valenzano Menada, M ^a   Moioli, M ^a   Mammoliti, S ^c   Costantini, S ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b VILLA SCASSI HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Early response evaluation; Locally advanced cervical cancer (LACC); Magnetic resonance imaging (MRI); Neoadjuvant chemotherapy (NACT)

Indexed keywords

CISPLATIN; IFOSFAMIDE; PACLITAXEL; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EVALUATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCALLY ADVANCED CERVICAL CANCER; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; UTERINE CERVIX CANCER; ADJUVANT THERAPY; CLINICAL TRIAL; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IFOSFAMIDE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TAXOIDS; UTERINE CERVICAL NEOPLASMS;

EID: 84860644609     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C. et al.: "Cancer Statistics, 2006". CA Cancer J. Clin., 2006, 56, 106.
2. Ozsarlak O., Tjalma W., Schepens E., Corthouts B., Op de Beeck B., Van Marck E. et al.: "The correlation of preoperative CT, MR imaging and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma". Eur. Radiol., 2003, 13, 2338.
3. De Vincenzo R., Amadio G., Ricci C., Licameli A., Ferrandina G., Capelli G. et al.: "Treatment of cervical cancer in Italy: strategies and their impact on the women". Vaccine, 2009, 27 (suppl. 1), A39.
4. Mabuchi S., Ugaki H., Isohashi F., Yoshioka Y., Temma K., Yada-Hashimoto N. et al.: "Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO Stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone". Gynecol. Obstet. Invest., 2010, 69, 224.
5. Benedetti Panici P., Bellati F., Pastore M., Manci N., Musella A., Pauselli S. et al.: "An update in neoadjuvant chemotherapy in cervical cancer". Gynecol. Oncol., 2007, 107 (1 suppl. 1), S20.
6. Loizzi V., Cormio G., Vicino M., Selvaggi L.: "Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer". Gynecol. Obstet. Invest., 2008, 65, 96.
7. Manfredi R., Maresca G., Smaniotto D., Greggi S., Andrulli D., Rabitti C et al.: "Cervical cancer response to neoadjuvant therapy: MR imaging assessment". Radiology, 1998, 209, 819.
8. Jeong Y.Y., Kang H.K., Chung T.W., Seo J.J., Park J.G.: "Uterine cervical carcinoma after therapy: CT and MR imaging findings". Radiographics, 2003, 23, 969.
9. Marchiolè P., Cittadini G., Sala P., Moioli M., Mathevet P., Capac-cio E. et al.: "Pre- and post-operative work-up in patients affected by early invasive cervical cancer and eligible for fertility sparing treatment: role of MRI with saline hydrocolpos". Abdom Imaging, 2010, 35, 271.
10. World Health Organization (WHO). WHO Handbook for reporting results for cancer treatment criteria. Geneva 1979.
11. Sardi J., Sananes C., Giaroli A., Maya G., di Paola G.: "Neoadjuvant chemotherapy in locally advanced carcinoma of cervix uteri". Gynecol. Oncol., 1990, 38, 486.
12. Benedetti-Panici P., Greggi S., Colombo A., Amoroso M., Smaniotto D., Giannarelli D. et al.: "Neoadjuvant chemotherapy and radical surgery versus exclusively radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multi-centre randomized study". J. Clin. Oncol., 2002, 1, 20, 179.
13. Benedetti Panici P., Greggi S., Scambia G., Amoroso M., Salerno M.G., Maneschi F. et al:. "Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer". Eur. J. Cancer, 1998, 34, 341.
14. Neoadjuvant chemotherapy for locally advanced cervical cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur. J. Cancer, 2003, 39, 2470.
15. Testa A.C., Ludovisi M., Manfredi R., Zannoni G., Gui B., Basso D. et al.: "Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer". Ultrasound Obstet. Gynecol., 2009, 34, 335.
16. Harry V.N.: "Novel imaging techniques as response biomarkers in cervical cancer". Gynecol. Oncol., 2010, 116, 253.
17. Payne G.S., Schmidt M., Morgan V.A., Giles S., Bridges J., Ind T. et al.: "Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in Stage I cervical cancer". Gynecol. Oncol., 2010, 116, 246.
18. Yuh W.T., Mayr N.A., Jarjoura D., Wu D., Grecula J.C., Lo S.S. et al.: "Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer". Invest. Radiol., 2009, 44, 343.